MARIBAVIR
Clinical Indication
Refractory cytomegalovirus infection after transplant
Comments
In line with NICE TA860
Date of classification
April 2023
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.